Continuous Glucose Monitoring (CGM) After Kidney Transplantation
Recruiting
Observational Study
Hyperglycaemia
Kidney Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 54 (estimated)
- Sponsor
- Bo Feldt-Rasmussen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes.
The primary objective is to analyse differences in mean sensor glucose between these three groups.
CGMs are applied to participants within 72 hours after kidney transplantation, with a …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Written informed consent obtained before CGM application
* Male or female; age: ≥18 years
* Kidney transplantation
Exclusion Criteria:
* Unable to cooperate to CGM the first ten days after surgery
* Allergic to plasters in CGM units
* Combined kidney and liver or pancreatic …
Contacts